missing translation for 'onlineSavingsMsg'
Learn More

Invitrogen™ Human LGI4 Synthetic Peptide

Numéro de catalogue. PEP0634
Modifier l'affichage
Click to view available options
Quantité:
50 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Numéro de catalogue. Quantité
PEP0634 50 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Numéro de catalogue. PEP0634 Fournisseur Invitrogen™ Code fournisseur PEP0634
Saison des économies
Afficher toutes les promotions

Pour de l'aide SVP utiliser la function de clavardage; nous envoyer un couriel à help@thermofisher.com ou appelez le service à la clientèle au 1-800-234-7437.

Synthetic Peptide

This peptide corresponds to 17 amino acids near the carboxy terminus of human LGI4. PEP-0634 can be used as a blocking peptide with polyclonal antibody PA5-20514.

The leucine-rich, glioma inactivated gene 4 (LGI4) is a member of the LGI family in which LGI1 is the exemplar. The LGI family consists of four of highly related proteins containing leucine-rich repeats (LRRs) which are highly similar to other transmembrane signaling molecules and receptors. LGI1 has been identified as a candidate tumor suppressor gene for glioma and plays a role in autodominant lateral temporal epilepsy (ADTLE), an epileptic syndrome characterized by focal seizures with predominant auditory symptoms. Despite its high homology with LGI1 and similar pattern of expression, mutations in LGI4 have not been found to be associated with ADTLE. However, the LGI4 gene is located in a region linked to benign familial infantile convulsions. Further study revealed that a GC-to-AT polymorphism was correlated with childhood absence epilepsy. Other studies showed that decreasing LGI4 expression in cultured cells inhibits myelination, indicating that LGI4 may play a role in neural development.

Spécifications

Espèces Human
Méthode de purification purified
Numéro d'enregistrement Q8N135
Nom usuel LGI4
Concentration 200 μg/mL
Format Liquid
Formule PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
Alias du gène clp; leucine rich repeat LGI family member 4; leucine-rich glioma inactivated protein 4; leucine-rich glioma-inactivated gene 4; leucine-rich glioma-inactivated protein 4; Leucine-rich repeat LGI family member 4; leucine-rich repeat LGI family, member 4; LGI1-like protein 3; LGI4; Lgil3; UNQ6515/PRO21485
Symbole de gène LGI4
Lyophilisé No
Conservateur Sodium azide
Type de produit Peptide
Quantité 50 μg
Statut réglementaire RUO
Afficher plus de résultats Afficher moins de résultats